Completed OBSERVATIONAL NCT05406024

Feasibility Study CORPPS (FAISA-CORPPS)

FEASIBILITY STUDY on the Use of a DIGITAL PLATFORM for Physical and Psychosocial RECONDITION After Major Neoplastic Surgery

Sponsor: ENGIE

Conditions Esophageal Neoplasm Laryngeal Neoplasms

Interventions Digital platform

Updated 5 times since 2022 Last updated: Dec 4, 2025 Started: Apr 3, 2023 Primary completion: Apr 19, 2024 Completion: Apr 19, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Esophageal Neoplasm and Laryngeal Neoplasms and is currently completed. ENGIE leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed

Status: Unknown → Completed
Sep 2024 — Jan 2026 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jul 2022 — Apr 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ENGIE
Fondation Boulanger
Santelys Association
University Hospital, Lille

Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lille, France